Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-11-19 00:00:00 ET · period of report 2024-11-15 · accession 0001601830-24-000214 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-15 | RXRX | Secora Michael | CFO | F - Tax | $6.18 | -11.9K | 1.49M | -0.8% | -$73.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-15 | F | D | 11,937 | $6.18 | 1,487,694 | D | — | — |